☆ 4.7 Letter

Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis

ANNALS OF THE RHEUMATIC DISEASES (2014)

期刊

ANNALS OF THE RHEUMATIC DISEASES

卷 73, 期 9, 页码 1746-+

出版社

BMJ PUBLISHING GROUP

DOI: 10.1136/annrheumdis-2014-205506

关键词

-

类别

Rheumatology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Rheumatology

Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years

Desiree van der Heijde, Mikkel Ostergaard, John D. Reveille, Xenofon Baraliakos, Andris Kronbergs, David M. Sandoval, Xiaoqi Li, Hilde Carlier, David H. Adams, Walter P. Maksymowych

Summary: This study evaluates the long-term effect of IXE on radiographic changes in the spine in patients with r-axSpA and identifies potential predictors of progression. The majority of patients had no radiographic progression in the spine through 2 years of treatment.

JOURNAL OF RHEUMATOLOGY (2022)

添加到收藏夹

Article Immunology

Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis

Liudan Tu, Churong Lin, Ya Xie, Xiaohong Wang, Qiujing Wei, Yanli Zhang, Jieruo Gu

Summary: This study found that patients with radiographic axial spondyloarthritis (r-axSpA) showed more active inflammatory and chronic structural damages on MRI compared to non-radiographic axial spondyloarthritis (nr-axSpA) patients, especially in terms of fat metaplasia and ankylosis.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Rheumatology

Tumor Necrosis Factor Inhibitors Reduce Spinal Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: A Longitudinal Analysis from the Alberta Prospective Cohort

Alexandre Sepriano, Sofia Ramiro, Stephanie Wichuk, Praveena Chiowchanwisawakit, Joel Paschke, Desiree van der Heijde, Robert Landewe, Walter P. Maksymowych

Summary: The study found that TNFi can slow down spinal radiographic progression in patients with radiographic axial SpA, which may be partially related to their effects on inflammation as measured by the ASDAS.

ARTHRITIS & RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis

Murat Torgutalp, Valeria Rios Rodriguez, Ani Dilbaryan, Fabian Proft, Mikhail Protopopov, Maryna Verba, Judith Rademacher, Hildrun Haibel, Joachim Sieper, Martin Rudwaleit, Denis Poddubnyy

Summary: This study aimed to analyze the association between treatment with tumour necrosis factor inhibitors (TNFi) and radiographic spinal progression in patients with axial spondyloarthritis (axSpA). The results showed that TNFi treatment in the current 2-year interval was not associated with retardation of radiographic spinal progression, but TNFi treatment in the previous 2-year interval was significantly associated with a reduction of mSASSS progression.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Article Orthopedics

Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements

John Charles Snow, Kyle Simpson, Proton Rahman, Samuel Howarth, Diana De Carvalho

Summary: The study evaluated the criterion-concurrent validity for a clinically feasible measurement method of measuring spine mobility using tri-axial accelerometers in patients with radiographic Spondyloarthritis. Results showed that the accelerometer method had stronger correlation to radiographic measures in forward bending, while tape measures performed better in lateral bending. The Lateral Spinal Flexion Test and Domjan Test showed the best criterion-concurrent validity among all tests examined in the study.

BMC MUSCULOSKELETAL DISORDERS (2021)

添加到收藏夹

Article Rheumatology

Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years

Caroline Ensslin, Raphael Micheroli, Seraphina Kissling, Andrea Gotschi, Kristina Burki, Rene Bram, Manouk de Hooge, Xenofon Baraliakos, Michael J. Nissen, Burkhard Moller, Pascale Exer, Michael Andor, Oliver Distler, Almut Scherer, Adrian Ciurea

Summary: This study investigated sex differences in spinal radiographic progression in axial spondyloarthritis. The results showed that spinal radiographic progression was more severe in men compared to women, with three times higher odds of progression in male patients, and this difference was mediated in part through an increase in baseline radiographic damage.

RMD OPEN (2023)

添加到收藏夹

Article Medicine, General & Internal

Computed tomography-based assessment of radiographic progression in spine and sacroiliac joints after pregnancy in women with radiographic axial spondyloarthritis

Kyung-Ann Lee, So Yun Lee, Se Hee Kim, Hyun-Sook Kim, Hae-Rim Kim, Sang-Hoon Lee

Summary: Pregnancy and delivery do not affect the radiographic progression of the spine and sacroiliac joints in women with radiographic axial spondyloarthritis.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Review Rheumatology

Challenges in non-radiographic axial spondyloarthritis

Denis Poddubnyy

Summary: This article discusses several challenges related to the concept, diagnosis, and treatment of non-radiographic axial spondyloarthritis (nr-axSpA) in the historical context and in light of recent data. The disease is part of the spectrum of axial spondyloarthritis and is characterized by the absence of definite structural damage in the sacroiliac joints. The introduction of the concept of nr-axSpA has stimulated activities aimed at improving the early diagnosis and treatment of this disease, but it has also raised controversial topics in the field.

JOINT BONE SPINE (2023)

添加到收藏夹

Article Rheumatology

Novel classification of axial spondyloarthritis to predict radiographic progression using machine learning

Y. B. Joo, I. -W. Baek, K. -S. Park, I. Tagkopoulos, K. -J. Kim

Summary: In this study, unbiased clustering analysis of phenotypic data identified three distinct subgroups of axSpA patients with different risk levels for radiographic progression. These subgroups showed significant differences in clinical characteristics and progression rates, which can be useful for risk stratification in the management of axSpA.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysis

Berthold Hoppe, Christian Schwedler, Hildrun Haibel, Maryna Verba, Fabian Proft, Mikhail Protopopov, Hans-Gert Heuft, Valeria Rios Rodriguez, Anke Edelmann, Martin Rudwaleit, Joachim Sieper, Denis Poddubnyy

Summary: This study found that in patients with axial spondyloarthritis, there is an association between C-reactive protein levels related to radiographic spinal progression and specific coagulation-related genotypes, especially in individuals predisposed to loose fibrin clots susceptible to fibrinolysis.

RMD OPEN (2021)

添加到收藏夹

Article Rheumatology

Machine-learning derived algorithms for prediction of radiographic progression in early axial spondyloarthritis

R. Garofoli, M. Resche-Rigon, C. Roux, D. van der Heijde, M. Dougados, A. Molto

Summary: This study compared the performance of machine learning and traditional models in predicting radiographic progression in patients with early axial spondyloarthritis. The results showed that traditional models were able to predict radiographic progression as accurately as machine learning models in this population.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry

Raphael Micheroli, Seraphina Kissling, Kristina Buerki, Burkhard Moeller, Axel Finckh, Michael J. Nissen, Pascale Exer, Rene Bram, Diego Kyburz, Andrea Rubbert-Roth, Michael Andor, Xenofon Baraliakos, Manouk de Hooge, Oliver Distler, Almut Scherer, Adrian Ciurea

Summary: This study aimed to investigate whether anaemia independently predicts spinal radiographic progression. The results showed that although anaemia was associated with higher disease activity in axSpA patients, it did not predict spinal radiographic progression.

CLINICAL RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Improving the design of RCTs in non-radiographic axial spondyloarthritis

Walter P. Maksymowych, Robert G. W. Lambert, Liron Caplan, Filip E. van den Bosch, Mikkel ostergaard

Summary: The current RCT design does not fully utilize MRI to select nr-axSpA patients who best demonstrate differences in clinical response rates between active drug and placebo therapies. Future studies should incorporate revised patient inclusion criteria based on expanded MRI evaluation and data-driven definitions of a positive MRI to improve discrimination between therapies.

NATURE REVIEWS RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

Can whole spine magnetic resonance imaging predict radiographic progression and inflammatory activity in axial spondyloarthritis?

Jung Gon Kim, Joon-Yong Jung, Jennifer Lee, Seung-Ki Kwok, Ji Hyeon Ju, Sung-Hwan Park, Wan-Uk Kim

Summary: This study found that initial whole spine MRI assessment can predict radiographic progression and subsequent systemic inflammatory burden in patients with axial spondyloarthritis (axSpA), particularly those without abnormalities on spine X-rays.

JOINT BONE SPINE (2022)

添加到收藏夹

Article Rheumatology

Anti-CD74 IgA autoantibodies in radiographic axial spondyloarthritis: a longitudinal Swedish study

Lan Do, Gabriel Granasen, Urban Hellman, Kristina Lejon, Mats Geijer, Xenofon Baraliakos, Torsten Witte, Helena Forsblad-d'Elia

Summary: This study investigated IgA anti-CD74 levels in patients with r-axSpA and found that plasma levels were significantly higher compared to controls, and independently associated with radiographic spinal changes. This suggests that IgA anti-CD74 may play a role in the pathogenesis of r-axSpA.

RHEUMATOLOGY (2021)

添加到收藏夹

Letter Rheumatology

Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewe

Dafna D. Gladman, Philip J. Mease, Paul Bird, Enrique R. Soriano, Soumya D. Chakravarty, May Shawi, Frederic Lavie, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai-Shan Tam, Philip S. Helliwell, Arthur Kavanaugh, Atul A. Deodhar, Mikkel Ostergaard, Xenofon Baraliakos

ANNALS OF THE RHEUMATIC DISEASES (2023)

添加到收藏夹

Article Rheumatology

Anatomical variation of the sacroiliac joint carries an increased risk for erosion and bone marrow oedema in axial spondyloarthritis

Katharina Ziegeler, Sevtap Tugce Ulas, Denis Poddubnyy, Fabian Proft, Valeria Rios Rodriguez, Judith Rademacher, Kay Geert A. Hermann, Torsten Diekhoff

Summary: Joint shape variations are associated with inflammatory lesions on SI joint MRIs in axSpA patients. This should be taken into consideration in future research on the interplay of mechanical strain and inflammation in axSpA.

RHEUMATOLOGY (2023)

添加到收藏夹

Review Rheumatology

Perioperative management of patients with inflammatory rheumatic diseases Updated recommendations of the German Society for Rheumatology

Katinka Albrecht, Denis Poddubnyy, Jan Leipe, Philipp Sewerin, Christof Iking-Konert, Roger Scholz, Klaus Krueger

Summary: This study provides updated recommendations on the use of anti-inflammatory medication for patients with inflammatory rheumatic diseases prior to surgery. The recommendations cover glucocorticoids, conventional synthetic disease-modifying antirheumatic drugs, biologics, and newer drugs and targeted synthetic DMARDs. The study highlights the importance of reducing glucocorticoid dose before surgery and suggests specific guidelines for different medications.

ZEITSCHRIFT FUR RHEUMATOLOGIE (2023)

添加到收藏夹

Article Rheumatology

Keep an Eye on the Back: Spondyloarthritis in Patients With Acute Anterior Uveitis

Judith Rademacher, Hanna Mullner, Torsten Diekhoff, Hildrun Haibel, Sabrina Igel, Dominika Pohlmann, Fabian Proft, Mikhail Protopopov, Valeria Rios Rodriguez, Murat Torgutalp, Uwe Pleyer, Denis Poddubnyy

Summary: This study aims to analyze the prevalence of spondyloarthritis (SpA) in patients with acute anterior uveitis (AAU), identify parameters associated with SpA, and evaluate referral algorithms for identifying patients with a high probability of having SpA. The study found a high prevalence of SpA in AAU patients, with the majority having predominantly axial SpA. Psoriasis, HLA-B27 positivity, elevated C-reactive protein level, and male sex were associated with the presence of SpA. The Dublin Uveitis Evaluation Tool (DUET) showed higher specificity than the Assessment of SpondyloArthritis international Society (ASAS) tool, but both strategies missed over 20% of AAU patients with SpA.

ARTHRITIS & RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials

Desiree van der Heijde, Atul Deodhar, Xenofon Baraliakos, Matthew A. Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M. Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S. Gensler, Nigil Haroon, Marina Magrey, Walter P. Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip van den Bosch, Thomas Vaux, Huji Xu

Summary: The BE MOBILE 1 and BE MOBILE 2 trials demonstrated that bimekizumab, a dual IL-17A and IL-17F inhibitor, improved efficacy outcomes in patients with axial spondyloarthritis (axSpA) and was well tolerated. These findings support the use of bimekizumab as a potential treatment option for axSpA.

ANNALS OF THE RHEUMATIC DISEASES (2023)

添加到收藏夹

Review Rheumatology

Challenges in non-radiographic axial spondyloarthritis

Denis Poddubnyy

Summary: This article discusses several challenges related to the concept, diagnosis, and treatment of non-radiographic axial spondyloarthritis (nr-axSpA) in the historical context and in light of recent data. The disease is part of the spectrum of axial spondyloarthritis and is characterized by the absence of definite structural damage in the sacroiliac joints. The introduction of the concept of nr-axSpA has stimulated activities aimed at improving the early diagnosis and treatment of this disease, but it has also raised controversial topics in the field.

JOINT BONE SPINE (2023)

添加到收藏夹

Review Rheumatology

Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version

Katinka Albrecht, Sebastian Binder, Kirsten Minden, Denis Poddubnyy, Anne C. Regierer, Anja Strangfeld, Johanna Callhoff

Summary: This study aimed to update the estimated prevalence of inflammatory rheumatic diseases (IRD) in Germany. The results showed that the prevalence of IRD in Germany is estimated to be 2.2-3.0%, with approximately 1.5-2.1 million affected individuals. However, the reliability of these data is uncertain due to the limitations of the studies.

ZEITSCHRIFT FUR RHEUMATOLOGIE (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Managing Psoriatic Arthritis Patients Presenting with Axial Symptoms

Denis Poddubnyy

Summary: A significant number of PsA patients exhibit symptoms of inflammatory axial involvement, requiring clinical and laboratory evaluation as well as axial imaging. Treatment for confirmed axial PsA includes non-pharmacologic and pharmacologic methods such as non-steroidal anti-inflammatory drugs, tumor necrosis factor, interleukin 17, and Janus kinase inhibitors.

DRUGS (2023)

添加到收藏夹

Correction Rheumatology

Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program (Feb, 10.3899/jrheum.221022, 2023)

Atul Deodhar, Denis Poddubnyy, Proton Rahman, Jeorg Ermann, Tetsuya Tomita, Rebeca Bolce, Soyi Liu Leage, Andris Kronbergs, Caroline Johnson, Joana Araujo, Ann Leung, Desiree van der Heijde

JOURNAL OF RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

New bone formation at the sacroiliac joint in axial spondyloarthritis: characterization of backfill in MRI and CT

Torsten Diekhoff, Denis Poddubnyy, Fabian Proft, Katharina Ziegeler, Dominik Deppe, Christoph Niedermeier, Kay Geert A. Hermann

Summary: By comparing CT and MRI scans of patients with axial SpA, it was found that joint space lesions show increased density and may contain calcified matrix, suggesting new bone formation. The proportion of calcified matrix gradually increases in type C lesions.

RHEUMATOLOGY (2023)

添加到收藏夹

Review Rheumatology

Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany

Katinka Albrecht, Sebastian Binder, Kirsten Minden, Denis Poddubnyy, Anne C. C. Regierer, Anja Strangfeld, Johanna Callhoff

Summary: This study aimed to update the prevalence estimates of inflammatory rheumatic diseases (IRD) in Germany. A systematic literature search identified original articles on prevalences for the period 2014-2022. The prevalence of IRD in Germany was estimated to be 2.2-3.0%, corresponding to approximately 1.5-2.1 million affected individuals.

ZEITSCHRIFT FUR RHEUMATOLOGIE (2023)

添加到收藏夹

Article Medicine, General & Internal

Dual-Energy-CT for Osteitis and Fat Lesions in Axial Spondyloarthritis: How Feasible Is Low-Dose Scanning?

Dominik Deppe, Katharina Ziegeler, Kay Geert A. Hermann, Fabian Proft, Denis Poddubnyy, Felix Radny, Marcus R. R. Makowski, Maximilian Muhle, Torsten Diekhoff

Summary: This study aimed to evaluate the ability of low-dose dual-energy computed tomography (ld-DECT) virtual non-calcium (VNCa) images to detect bone marrow pathologies in patients with axial spondyloarthritis (axSpA). Sixty-eight patients underwent both ld-DECT and MRI for assessment. The accuracy of ld-DECT in detecting osteitis and fatty bone marrow deposition was evaluated, and correlations with MRI were calculated. The results showed that ld-DECT had limited sensitivity and specificity in detecting these pathologies, and higher radiation might be needed for more accurate analysis.

DIAGNOSTICS (2023)

添加到收藏夹

Article Rheumatology

Self-reported diagnostic confidence predicts diagnostic accuracy in axial spondyloarthritis imaging

Sevtap Tugce Ulas, Felix Radny, Katharina Ziegeler, Iris Eshed, Juliane Greese, Dominik Deppe, Carsten Stelbrink, Robert Biesen, Hildrun Haibel, Valeria Rios Rodriguez, Judith Rademacher, Mikhail Protopopov, Fabian Proft, Denis Poddubnyy, Torsten Diekhoff

Summary: This study aimed to investigate whether self-reported diagnostic confidence can predict diagnostic accuracy in axial spondyloarthritis imaging. The results showed significant differences in diagnostic confidence between correct and incorrect responses for all imaging modalities, and self-reported diagnostic confidence can serve as useful information to predict diagnostic reliability.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis

Juergen Braun, Ricardo Blanco, Helena Marzo-Ortega, Lianne S. Gensler, Filip van den Bosch, Stephen Hall, Hideto Kameda, Denis Poddubnyy, Marleen van de Sande, Desiree van der Heijde, Tingting Zhuang, Anna Stefanska, Aimee Readie, Hanno B. Richards, Atul Deodhar

Summary: This study reports the radiographic progression and course of inflammation in patients with non-radiographic axial spondyloarthritis (nr-axSpA) over 2 years. The results show that most patients did not experience further structural damage in the sacroiliac joints and spine, and treatment with secukinumab effectively reduced inflammation in the sacroiliac joints.

ARTHRITIS RESEARCH & THERAPY (2023)

添加到收藏夹

Article Rheumatology

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib

Lars E. Kristensen, Bruce Strober, Denis Poddubnyy, Ying-Ying Leung, Hyejin Jo, Kenneth Kwok, Ivana Vranic, Dona L. Fleishaker, Lara Fallon, Arne Yndestad, Dafna D. Gladman

Summary: This study analyzed the association between baseline cardiovascular disease risk and the occurrence of major adverse cardiovascular events and malignancies in tofacitinib-treated patients with PsA and PsO. The results showed that patients with increased ASCVD risk and baseline metabolic syndrome had higher incidence rates for MACE and malignancies. It highlights the importance of assessing CV risk and enhancing cancer monitoring in patients with PsA and PsO.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.